Results 171 to 180 of about 73,145 (294)
Renal tubular lysozyme in tubulointerstitial diseases and renal sarcoidosis. [PDF]
Sanada S, Sato M.
europepmc +1 more source
Osmotic nephropathy as a potentially underrecognized cause of acute kidney injury during SGLT2 inhibitor therapy: a case report and literature review. [PDF]
Murata A +9 more
europepmc +1 more source
Modeling the Effects of Multiple Myeloma on Kidney Function
Multiple myeloma (MM), a plasma cell cancer, is associated with many health challenges, including damage to the kidney by tubulointerstitial fibrosis.
Ayati, Bruce P. +2 more
core
Translating cardiovascular ion channel and Ca2+ signalling mechanisms into therapeutic insights
Abstract figure legend This white paper integrates mechanistic discoveries across ion channel biology, Ca2+ signalling and multiscale cardiovascular physiology to highlight new opportunities for accelerating research and guiding next‐generation therapies.
Silvia Marchianò +18 more
wiley +1 more source
Suggestions for attenuation of renal ischemia reperfusion injury based on mechanisms involved in epithelial cells damages [PDF]
Tavafi Majid
doaj
Imbalance of mitochondria and abnormalities in lipid metabolism in Diabetic Tubulopathy. [PDF]
Sun C, Li Y, Tao Y, Wu Q, Liu B, Zhou Y.
europepmc +1 more source
ABSTRACT Purpose The aim is to evaluate the effectiveness of timed breathing in reducing respiratory motion artifacts in renal chemical exchange saturation transfer (CEST) MRI and to assess potential differences in CEST effects between renal compartments.
Patrik Jan Gallinnis +10 more
wiley +1 more source
Sex-Related Expression of Klotho in Rat Kidneys: Species Differences Between Rats and Mice. [PDF]
Breljak D +16 more
europepmc +1 more source
This manuscript describes the scope of implementation and impact of a regulatory agency‐qualified panel of six urine biomarkers on drug development, the process for which was conducted and funded by the Critical Path Institute, the Foundation for the National Institutes of Health, and the United States Food and Drug Administration.
Tanja S. Zabka +7 more
wiley +1 more source
Hepato‐renal protective potential of DMF in alloxan‐induced diabetic mice model. ABSTRACT Aim Despite advances in diabetes treatments, the effects of this disease have not yet been adequately reversed or prevented in patients. Therefore, development of more effective medication‐assisted treatments in this field is needed.
Parisa Saberi‐Hasanabadi +5 more
wiley +1 more source

